Remote Monitoring

Remote cardiac monitoring technologies enable patient health to be tracked outside the clinical setting. It can be used for longer term monitoring to help diagnosis arrhythmias or other cardiac conditions. Remote monitoring also can keep tabs on chronic conditions such as heart failure or hypertension and alert clinicians to worsening symptoms to avoid an acute care episode or hospitalization.

FDA clears Google smartwatch tech that calls 911 when a user’s heart stops
Google worked with AI specialists, cardiologists and even stunt performers to develop its new smartwatch feature.
Wearable heart device company to go public, raise up to $155M
Kestra Medical Technologies, known for its wearable heart monitors and defibrillators, intends to sell 10 million common shares priced somewhere between $14 and $16 per share.
FDA announces Class I recall of Boston Scientific pacemakers—replacement may be necessary
These safety issues have been linked to more than 800 injuries and two deaths. It is possible, the FDA warned, that some patients may require a device to be removed and replaced.
Post-stroke follow-up care considerably worse for women than men
Female stroke survivors are less likely to receive a cardiology referral or undergo cardiac monitoring than their male counterparts.
FDA warns of cybersecurity vulnerabilities in patient monitors
The agency said Contec and Epsimed monitors connected via WiFi are particularly susceptible to cyberattack and could be used to gain access to hospital systems.

New wearable device, no bigger than a stamp, uses AI to deliver on-the-go cardiac imaging

New stamp-sized wearable device uses AI to deliver on-the-go cardiac imaging

The device, designed to be worn for up to 24 hours at a time, uses ultrasound technology and artificial intelligence to track how much blood the user's heart is pumping.

The Dexcom G7 Continuous Glucose Monitoring System

Regulatory Roundup: FDA news on omecamtiv mecarbil for HFrEF, 'world's smallest heart pump' and more

Read our monthly recap of some of the biggest FDA-related stories that have hit cardiology, including updates related to Cytokinetics, Dexcom and Abiomed.

wearable device heart health ECG SCG ultra soft University of Missouri Zheng Yan, PhD

New ‘ultra-soft’ wearable device uses ECG, SCG results to monitor heart health

The new-look device, still under development, is designed to be worn for weeks at a time.

The power of AI: Advanced algorithm IDs heart issues using Apple Watch data

A team of Mayo Clinic specialists led the analysis, sharing their findings in Nature Medicine.

cardiologist patient heart compensation starting salary 2022 interventional cardiologist

Researchers awarded $31M to study conduction system pacing among heart failure patients

“Once the study begins, it will likely be one of the largest heart pacing clinical trials happening in the world over the next few years," one specialist said.

Smartphones show potential to double as electronic stethoscopes

The application, called Echoes, was designed with help from the British Heart Foundation and Evelina Children’s Heart Organization. It uses an iPhone's built-in microphone to capture recordings of the user's heart.

Researchers awarded $37M to see if Apple Watch can lower stroke risk among AFib patients

Could wearables help AFib patients take fewer blood-thinning medications and reduce their risk of stroke? The team behind a new seven-year analysis hopes to find out.

The U.S. Food and Drug Administration (FDA) has granted the first pediatric indication for use for an implantable cardiac monitor to Medtronic. The Linq II Insertable Cardiac Monitor (ICM) system is the first such device receive 510(k) clearance for use in pediatric patients over the age of 2 who have heart rhythm abnormalities and require long-term, continuous monitoring.

FDA grants new pediatric indication for Medtronic Linq II implantable cardiac monitor

The FDA granted the first pediatric indication for an implantable cardiac monitor. The Linq II can be used in pediatric patients over the age of 2 for up to 4.5 years of long-term, continuous monitoring.

Remote Monitoring

FDA clears Google smartwatch tech that calls 911 when a user’s heart stops

Wearable heart device company to go public, raise up to $155M

FDA announces Class I recall of Boston Scientific pacemakers—replacement may be necessary

Post-stroke follow-up care considerably worse for women than men

FDA warns of cybersecurity vulnerabilities in patient monitors